By quantizing weights with different precision for different parts of a network, mixed-precision quantization promises to reduce the hardware cost and improve the speed of deep neural network (DNN) ...

Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its ...

UBS reaffirmed its Buy rating and $105 target for Merck, brushing off investor pessimism about the pharmaceutical giant’s ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis ...

Merck shareholders backed a call for greater tax transparency. Jason Ward explores what this means for Big Pharma, investors, ...

Merck's Winrevair reduced clinical worsening in PAH patients in the Phase 3 HYPERION trial, building on prior positive study outcomes.

Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints. On Monday, the pharmaceutical company said it has received positive topline results ...

The Merck Foundation hosted its 7th Merck Foundation First Ladies Initiative (MFFLI) Summit in Dubai, focusing on enhancing healthcare in Africa and Asia. Esteemed guests included First Ladies from 14 ...

MSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan (I-DXd) against docetaxel in individuals with metastatic ...

Abbott and MSD Pharmaceuticals on Wednesday announced a strategic distribution partnership to expand access to MSD’s oral anti-diabetic portfolio in India, including sitagliptin and its fixed ...

Editor’s note: This story was updated at 8:47 a.m. June 19, 2025, to note that Merck Manuals – a separate entity from Merck – launched the new tool.